カテゴリー： QYResearch, 世界

拡張型心筋症治療薬の世界市場：規模・現状・予測2019-2025

【英語タイトル】Global Dilated Cardiomyopathy Therapeutics Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料（DATA909X18387）・商品コード：DATA909X18387
・発行会社（調査会社）：QYResearch
・発行日：2019年11月25日（※2024年版があります。お問い合わせください）
・ページ数：92
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥577,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥865,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,800 ⇒換算￥1,154,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※当調査レポートでは、拡張型心筋症治療薬の世界市場について調査・分析し、拡張型心筋症治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（薬物クラス、植込み型デバイス、パイプライン分析）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。


・レポートの概要
・世界の拡張型心筋症治療薬市場動向
・主要企業別マーケットシェア
・拡張型心筋症治療薬の種類別市場規模2014-2019
（薬物クラス、植込み型デバイス、パイプライン分析）
・拡張型心筋症治療薬の用途別市場規模2014-2019
（病院、診療所、その他）
・拡張型心筋症治療薬の北米市場：主要企業・種類別/用途別市場規模
・拡張型心筋症治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模
・拡張型心筋症治療薬の中国市場：主要企業・種類別/用途別市場規模
・拡張型心筋症治療薬の日本国内市場：主要企業・種類別/用途別市場規模
・拡張型心筋症治療薬の東南アジア市場：主要企業・種類別/用途別市場規模
・拡張型心筋症治療薬のインド市場：主要企業・種類別/用途別市場規模
・拡張型心筋症治療薬の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Aastrom Biosciences、Capricor Therapeutics、GlaxoSmithkline Plc、Johnson and Johnson、Kasiak Research Pvt. Ltd.、Merck & Co., Inc.、MyoKardia, Pfizer, Inc.、t2cure, GmbH、Teva Pharmaceutical Industries、ZensunSci & Tech）
・拡張型心筋症治療薬の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...
【レポートの概要】

Dilated cardiomyopathy (DCM) is a condition in which the heart’s ability to pump blood is decreased because the heart’s main pumping chamber, the left ventricle, is enlarged and weakened. In some cases, it prevents the heart from relaxing and filling with blood as it should.In 2018, the global Dilated Cardiomyopathy Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Dilated Cardiomyopathy Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Dilated Cardiomyopathy Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Aastrom Biosciences
Capricor Therapeutics
GlaxoSmithkline Plc
Johnson and Johnson
Kasiak Research Pvt. Ltd.
Merck & Co., Inc.
MyoKardia, Pfizer, Inc.
t2cure, GmbH
Teva Pharmaceutical Industries
ZensunSci & Tech

Market segment by Type, the product can be split into
Drug Class
Implantable Device
Pipeline Analysis

Market segment by Application, split into
Hospitals
Clinic
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Dilated Cardiomyopathy Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Dilated Cardiomyopathy Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Dilated Cardiomyopathy Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Dilated Cardiomyopathy Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Drug Class
1.4.3 Implantable Device
1.4.4 Pipeline Analysis
1.5 Market by Application
1.5.1 Global Dilated Cardiomyopathy Therapeutics Market Share by Application (2019-2025)
1.5.2 Hospitals
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Dilated Cardiomyopathy Therapeutics Market Size
2.2 Dilated Cardiomyopathy Therapeutics Growth Trends by Regions
2.2.1 Dilated Cardiomyopathy Therapeutics Market Size by Regions (2019-2025)
2.2.2 Dilated Cardiomyopathy Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Dilated Cardiomyopathy Therapeutics Market Size by by Players
3.1.1 Global Dilated Cardiomyopathy Therapeutics Revenue by by Players (2014-2019)
3.1.2 Global Dilated Cardiomyopathy Therapeutics Revenue Market Share by by Players (2014-2019)
3.1.3 Global Dilated Cardiomyopathy Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Dilated Cardiomyopathy Therapeutics Key Players Head office and Area Served
3.3 Key Players Dilated Cardiomyopathy Therapeutics Product/Solution/Service
3.4 Date of Enter into Dilated Cardiomyopathy Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Dilated Cardiomyopathy Therapeutics Market Size by Type (2014-2019)
4.2 Global Dilated Cardiomyopathy Therapeutics Market Size by Application (2014-2019)

5 North America
5.1 North America Dilated Cardiomyopathy Therapeutics Market Size (2014-2019)
5.2 Dilated Cardiomyopathy Therapeutics Key Players in North America
5.3 North America Dilated Cardiomyopathy Therapeutics Market Size by Type
5.4 North America Dilated Cardiomyopathy Therapeutics Market Size by Application

6 Europe
6.1 Europe Dilated Cardiomyopathy Therapeutics Market Size (2014-2019)
6.2 Dilated Cardiomyopathy Therapeutics Key Players in Europe
6.3 Europe Dilated Cardiomyopathy Therapeutics Market Size by Type
6.4 Europe Dilated Cardiomyopathy Therapeutics Market Size by Application

7 China
7.1 China Dilated Cardiomyopathy Therapeutics Market Size (2014-2019)
7.2 Dilated Cardiomyopathy Therapeutics Key Players in China
7.3 China Dilated Cardiomyopathy Therapeutics Market Size by Type
7.4 China Dilated Cardiomyopathy Therapeutics Market Size by Application

8 Japan
8.1 Japan Dilated Cardiomyopathy Therapeutics Market Size (2014-2019)
8.2 Dilated Cardiomyopathy Therapeutics Key Players in Japan
8.3 Japan Dilated Cardiomyopathy Therapeutics Market Size by Type
8.4 Japan Dilated Cardiomyopathy Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Dilated Cardiomyopathy Therapeutics Market Size (2014-2019)
9.2 Dilated Cardiomyopathy Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Dilated Cardiomyopathy Therapeutics Market Size by Type
9.4 Southeast Asia Dilated Cardiomyopathy Therapeutics Market Size by Application

10 India
10.1 India Dilated Cardiomyopathy Therapeutics Market Size (2014-2019)
10.2 Dilated Cardiomyopathy Therapeutics Key Players in India
10.3 India Dilated Cardiomyopathy Therapeutics Market Size by Type
10.4 India Dilated Cardiomyopathy Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Dilated Cardiomyopathy Therapeutics Market Size (2014-2019)
11.2 Dilated Cardiomyopathy Therapeutics Key Players in Central & South America
11.3 Central & South America Dilated Cardiomyopathy Therapeutics Market Size by Type
11.4 Central & South America Dilated Cardiomyopathy Therapeutics Market Size by Application

12 International Players Profiles
12.1 Aastrom Biosciences
12.1.1 Aastrom Biosciences Company Details
12.1.2 Company Description and Business Overview
12.1.3 Dilated Cardiomyopathy Therapeutics Introduction
12.1.4 Aastrom Biosciences Revenue in Dilated Cardiomyopathy Therapeutics Business (2014-2019))
12.1.5 Aastrom Biosciences Recent Development
12.2 Capricor Therapeutics
12.2.1 Capricor Therapeutics Company Details
12.2.2 Company Description and Business Overview
12.2.3 Dilated Cardiomyopathy Therapeutics Introduction
12.2.4 Capricor Therapeutics Revenue in Dilated Cardiomyopathy Therapeutics Business (2014-2019)
12.2.5 Capricor Therapeutics Recent Development
12.3 GlaxoSmithkline Plc
12.3.1 GlaxoSmithkline Plc Company Details
12.3.2 Company Description and Business Overview
12.3.3 Dilated Cardiomyopathy Therapeutics Introduction
12.3.4 GlaxoSmithkline Plc Revenue in Dilated Cardiomyopathy Therapeutics Business (2014-2019)
12.3.5 GlaxoSmithkline Plc Recent Development
12.4 Johnson and Johnson
12.4.1 Johnson and Johnson Company Details
12.4.2 Company Description and Business Overview
12.4.3 Dilated Cardiomyopathy Therapeutics Introduction
12.4.4 Johnson and Johnson Revenue in Dilated Cardiomyopathy Therapeutics Business (2014-2019)
12.4.5 Johnson and Johnson Recent Development
12.5 Kasiak Research Pvt. Ltd.
12.5.1 Kasiak Research Pvt. Ltd. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Dilated Cardiomyopathy Therapeutics Introduction
12.5.4 Kasiak Research Pvt. Ltd. Revenue in Dilated Cardiomyopathy Therapeutics Business (2014-2019)
12.5.5 Kasiak Research Pvt. Ltd. Recent Development
12.6 Merck & Co., Inc.
12.6.1 Merck & Co., Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Dilated Cardiomyopathy Therapeutics Introduction
12.6.4 Merck & Co., Inc. Revenue in Dilated Cardiomyopathy Therapeutics Business (2014-2019)
12.6.5 Merck & Co., Inc. Recent Development
12.7 MyoKardia, Pfizer, Inc.
12.7.1 MyoKardia, Pfizer, Inc. Company Details
12.7.2 Company Description and Business Overview
12.7.3 Dilated Cardiomyopathy Therapeutics Introduction
12.7.4 MyoKardia, Pfizer, Inc. Revenue in Dilated Cardiomyopathy Therapeutics Business (2014-2019)
12.7.5 MyoKardia, Pfizer, Inc. Recent Development
12.8 t2cure, GmbH
12.8.1 t2cure, GmbH Company Details
12.8.2 Company Description and Business Overview
12.8.3 Dilated Cardiomyopathy Therapeutics Introduction
12.8.4 t2cure, GmbH Revenue in Dilated Cardiomyopathy Therapeutics Business (2014-2019)
12.8.5 t2cure, GmbH Recent Development
12.9 Teva Pharmaceutical Industries
12.9.1 Teva Pharmaceutical Industries Company Details
12.9.2 Company Description and Business Overview
12.9.3 Dilated Cardiomyopathy Therapeutics Introduction
12.9.4 Teva Pharmaceutical Industries Revenue in Dilated Cardiomyopathy Therapeutics Business (2014-2019)
12.9.5 Teva Pharmaceutical Industries Recent Development
12.10 ZensunSci & Tech
12.10.1 ZensunSci & Tech Company Details
12.10.2 Company Description and Business Overview
12.10.3 Dilated Cardiomyopathy Therapeutics Introduction
12.10.4 ZensunSci & Tech Revenue in Dilated Cardiomyopathy Therapeutics Business (2014-2019)
12.10.5 ZensunSci & Tech Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Dilated Cardiomyopathy Therapeutics Key Market Segments
Table Key Players Dilated Cardiomyopathy Therapeutics Covered
Table Global Dilated Cardiomyopathy Therapeutics Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Drug Class Figures
Table Key Players of Drug Class
Figuer Implantable Device Figures
Table Key Players of Implantable Device
Figuer Pipeline Analysis Figures
Table Key Players of Pipeline Analysis
Table Global Dilated Cardiomyopathy Therapeutics Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Dilated Cardiomyopathy Therapeutics Market Share by Application in 2018 & 2025
Figure Hospitals Case Studies
Figure Clinic Case Studies
Figure Others Case Studies
Figure Dilated Cardiomyopathy Therapeutics Report Years Considered
Figure Global Dilated Cardiomyopathy Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Dilated Cardiomyopathy Therapeutics Market Size by Regions 2019-2025 (Million US$)
Table Global Dilated Cardiomyopathy Therapeutics Market Size by Regions 2019-2025 (Million US$)
Table Global Dilated Cardiomyopathy Therapeutics Market Share by Regions 2014-2019
Figure Global Dilated Cardiomyopathy Therapeutics Market Share by Regions 2014-2019
Figure Global Dilated Cardiomyopathy Therapeutics Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Dilated Cardiomyopathy Therapeutics Revenue by by Players (2014-2019) (Million US$)
Table Global Dilated Cardiomyopathy Therapeutics Market Share by by Players (2014-2019)
Figure Global Dilated Cardiomyopathy Therapeutics Market Share by by Players in 2018
Table Global Dilated Cardiomyopathy Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Dilated Cardiomyopathy Therapeutics Product/Solution/Service
Table Date of Enter into Dilated Cardiomyopathy Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Dilated Cardiomyopathy Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Dilated Cardiomyopathy Therapeutics Market Size Share by Type (2014-2019)
Figure Global Dilated Cardiomyopathy Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Dilated Cardiomyopathy Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Dilated Cardiomyopathy Therapeutics Market Size Share by Application (2014-2019)
Figure Global Dilated Cardiomyopathy Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Dilated Cardiomyopathy Therapeutics Revenue Market Share by Application in 2018
Figure North America Dilated Cardiomyopathy Therapeutics Market Size 2014-2019 (Million US$)
Table North America Key Players Dilated Cardiomyopathy Therapeutics Revenue (2018-2019) (Million US$)
Table North America Key Players Dilated Cardiomyopathy Therapeutics Market Share (2018-2019)
Table North America Dilated Cardiomyopathy Therapeutics Market Size by Type 2014-2019 (Million US$)
Table North America Dilated Cardiomyopathy Therapeutics Market Share by Type 2014-2019
Table North America Dilated Cardiomyopathy Therapeutics Market Size by Application 2014-2019 (Million US$)
Table North America Dilated Cardiomyopathy Therapeutics Market Share by Application 2014-2019
Figure Europe Dilated Cardiomyopathy Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Dilated Cardiomyopathy Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Dilated Cardiomyopathy Therapeutics Market Share (2018-2019)
Table Europe Dilated Cardiomyopathy Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Europe Dilated Cardiomyopathy Therapeutics Market Share by Type 2014-2019
Table Europe Dilated Cardiomyopathy Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Europe Dilated Cardiomyopathy Therapeutics Market Share by Application 2014-2019
Figure China Dilated Cardiomyopathy Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Dilated Cardiomyopathy Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Dilated Cardiomyopathy Therapeutics Market Share (2018-2019)
Table China Dilated Cardiomyopathy Therapeutics Market Size by Type 2014-2019 (Million US$)
Table China Dilated Cardiomyopathy Therapeutics Market Share by Type 2014-2019
Table China Dilated Cardiomyopathy Therapeutics Market Size by Application 2014-2019 (Million US$)
Table China Dilated Cardiomyopathy Therapeutics Market Share by Application 2014-2019
Figure Japan Dilated Cardiomyopathy Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Dilated Cardiomyopathy Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Dilated Cardiomyopathy Therapeutics Market Share (2018-2019)
Table Japan Dilated Cardiomyopathy Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Japan Dilated Cardiomyopathy Therapeutics Market Share by Type 2014-2019
Table Japan Dilated Cardiomyopathy Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Japan Dilated Cardiomyopathy Therapeutics Market Share by Application 2014-2019
Figure Southeast Asia Dilated Cardiomyopathy Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Dilated Cardiomyopathy Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Dilated Cardiomyopathy Therapeutics Market Share (2018-2019)
Table Southeast Asia Dilated Cardiomyopathy Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Dilated Cardiomyopathy Therapeutics Market Share by Type 2014-2019
Table Southeast Asia Dilated Cardiomyopathy Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Dilated Cardiomyopathy Therapeutics Market Share by Application 2014-2019
Figure India Dilated Cardiomyopathy Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Dilated Cardiomyopathy Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Dilated Cardiomyopathy Therapeutics Market Share (2018-2019)
Table India Dilated Cardiomyopathy Therapeutics Market Size by Type 2014-2019 (Million US$)
Table India Dilated Cardiomyopathy Therapeutics Market Share by Type 2014-2019
Table India Dilated Cardiomyopathy Therapeutics Market Size by Application 2014-2019 (Million US$)
Table India Dilated Cardiomyopathy Therapeutics Market Share by Application 2014-2019
Figure Central & South America Dilated Cardiomyopathy Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Dilated Cardiomyopathy Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Dilated Cardiomyopathy Therapeutics Market Share (2018-2019)
Table Central & South America Dilated Cardiomyopathy Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Central & South America Dilated Cardiomyopathy Therapeutics Market Share by Type 2014-2019
Table Central & South America Dilated Cardiomyopathy Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Central & South America Dilated Cardiomyopathy Therapeutics Market Share by Application 2014-2019
Table Aastrom Biosciences Company Details
Table Aastrom Biosciences Revenue in Dilated Cardiomyopathy Therapeutics Business 2014-2019 (Million US$)
Figure Aastrom Biosciences Revenue Growth Rate in Dilated Cardiomyopathy Therapeutics Business (2014-2019)
Table Aastrom Biosciences Recent Development
Table Capricor Therapeutics Company Details
Table Capricor Therapeutics Revenue in Dilated Cardiomyopathy Therapeutics Business 2014-2019 (Million US$)
Figure Capricor Therapeutics Revenue Growth Rate in Dilated Cardiomyopathy Therapeutics Business (2014-2019)
Table Capricor Therapeutics Recent Development
Table GlaxoSmithkline Plc Company Details
Table GlaxoSmithkline Plc Revenue in Dilated Cardiomyopathy Therapeutics Business 2014-2019 (Million US$)
Figure GlaxoSmithkline Plc Revenue Growth Rate in Dilated Cardiomyopathy Therapeutics Business (2014-2019)
Table GlaxoSmithkline Plc Recent Development
Table Johnson and Johnson Company Details
Table Johnson and Johnson Revenue in Dilated Cardiomyopathy Therapeutics Business 2014-2019 (Million US$)
Figure Johnson and Johnson Revenue Growth Rate in Dilated Cardiomyopathy Therapeutics Business (2014-2019)
Table Johnson and Johnson Recent Development
Table Kasiak Research Pvt. Ltd. Company Details
Table Kasiak Research Pvt. Ltd. Revenue in Dilated Cardiomyopathy Therapeutics Business 2014-2019 (Million US$)
Figure Kasiak Research Pvt. Ltd. Revenue Growth Rate in Dilated Cardiomyopathy Therapeutics Business (2014-2019)
Table Kasiak Research Pvt. Ltd. Recent Development
Table Merck & Co., Inc. Company Details
Table Merck & Co., Inc. Revenue in Dilated Cardiomyopathy Therapeutics Business 2014-2019 (Million US$)
Figure Merck & Co., Inc. Revenue Growth Rate in Dilated Cardiomyopathy Therapeutics Business (2014-2019)
Table Merck & Co., Inc. Recent Development
Table MyoKardia, Pfizer, Inc. Company Details
Table MyoKardia, Pfizer, Inc. Revenue in Dilated Cardiomyopathy Therapeutics Business 2014-2019 (Million US$)
Figure MyoKardia, Pfizer, Inc. Revenue Growth Rate in Dilated Cardiomyopathy Therapeutics Business (2014-2019)
Table MyoKardia, Pfizer, Inc. Recent Development
Table t2cure, GmbH Company Details
Table t2cure, GmbH Revenue in Dilated Cardiomyopathy Therapeutics Business 2014-2019 (Million US$)
Figure t2cure, GmbH Revenue Growth Rate in Dilated Cardiomyopathy Therapeutics Business (2014-2019)
Table t2cure, GmbH Recent Development
Table Teva Pharmaceutical Industries Company Details
Table Teva Pharmaceutical Industries Revenue in Dilated Cardiomyopathy Therapeutics Business 2014-2019 (Million US$)
Figure Teva Pharmaceutical Industries Revenue Growth Rate in Dilated Cardiomyopathy Therapeutics Business (2014-2019)
Table Teva Pharmaceutical Industries Recent Development
Table ZensunSci & Tech Company Details
Table ZensunSci & Tech Revenue in Dilated Cardiomyopathy Therapeutics Business 2014-2019 (Million US$)
Figure ZensunSci & Tech Revenue Growth Rate in Dilated Cardiomyopathy Therapeutics Business (2014-2019)
Table ZensunSci & Tech Recent Development
Table Global Dilated Cardiomyopathy Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Dilated Cardiomyopathy Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Dilated Cardiomyopathy Therapeutics Market Size Share by Regions in 2025
Figure North America Dilated Cardiomyopathy Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Dilated Cardiomyopathy Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Dilated Cardiomyopathy Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Dilated Cardiomyopathy Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Dilated Cardiomyopathy Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Dilated Cardiomyopathy Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Dilated Cardiomyopathy Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Dilated Cardiomyopathy Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Dilated Cardiomyopathy Therapeutics Market Size by Product (2019-2025)
Figure Global Dilated Cardiomyopathy Therapeutics Market Size by Product in 2025
Table Global Dilated Cardiomyopathy Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Dilated Cardiomyopathy Therapeutics Market Size by Application (2019-2025)
Figure Global Dilated Cardiomyopathy Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Aastrom Biosciences、Capricor Therapeutics、GlaxoSmithkline Plc、Johnson and Johnson、Kasiak Research Pvt. Ltd.、Merck & Co., Inc.、MyoKardia, Pfizer, Inc.、t2cure, GmbH、Teva Pharmaceutical Industries、ZensunSci & Tech

★調査レポート[拡張型心筋症治療薬の世界市場：規模・現状・予測2019-2025] (コード：DATA909X18387)販売に関する免責事項を必ずご確認ください。
★調査レポート[拡張型心筋症治療薬の世界市場：規模・現状・予測2019-2025]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の犬用拡張型心筋症薬産業：成長傾向・競合分析2019-2025
    DATA909X00400 / QYResearch / 2019年11月22日 / ※本調査レポートでは、世界の犬用拡張型心筋症薬市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。犬用拡張型心筋症薬の種類別には、経口、注射剤に、用途別には、オンライン、オフラインに、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・犬用拡張型心筋症薬の種類別市場規模：経口、注射剤 ・犬用拡張型心筋症薬の用途別市場規模：オンライン、オフライン ・犬用拡張型心筋症薬の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：C. H. Boehringer...Canine dilated cardiomyopathy drugs are used to treat heart muscle diseases which causes the heart to weaken and enlarge. This results in weaken contraction and poor pumping ability of the heart. The canine dilated cardiomyopathy is prevalent in certain breeds of dog and observed to be rare in crossbreeds dogs. Canine dilated cardiomyopathy drugs are directed at enhancing systolic (pump) function of the heart, dilating the peripheral blood vessels to lower ventricular workload, controlling heart rate and cardiac arrhythmias. Canine dilated cardiomyopathy drugs treatment goals are achieved by the administration of cardiac medication which may be delivered through injections in...
  • アテローム性動脈硬化症治療薬の世界市場：規模・現状・予測2019-2025
    DATA909X18181 / QYResearch / 2019年11月25日 / ※当調査レポートでは、アテローム性動脈硬化症治療薬の世界市場について調査・分析し、アテローム性動脈硬化症治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（小分子、生物製剤）、用途別（病院、クリニック、研究所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のアテローム性動脈硬化症治療薬市場動向 ・主要企業別マーケットシェア ・アテローム性動脈硬化症治療薬の種類別市場規模2014-2019 （小分子、生物製剤） ・アテローム性動脈硬化症治療薬の用途別市場規模2014-2019 （病院、クリニック、研究所、その他） ・アテローム性動脈硬化症治療薬の北米市場：主要企業・種類別/用途別市場規模 ・アテローム性動脈硬化症治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模...Atherosclerosis is a disease in which the inside of an artery narrows due to the build up of plaque.The identification of new drug targets for atherosclerosis will be one of the critical atherosclerosis therapeutics market trends driving the growth of the market. Although statins are regarded as the first line of treatment for decreasing LDL levels in the body, it exhibits secondary effects, such as hepatic enzyme elevation or muscular pain in some patients. Moreover, statins do not decrease the risk of cardiovascular diseases completely and is not recommended for patients having diabetes. This has encouraged researchers to focus on...
  • 脾腫治療法の世界市場：規模・現状・予測2019-2025
    DATA909X18996 / QYResearch / 2019年11月25日 / ※当調査レポートでは、脾腫治療法の世界市場について調査・分析し、脾腫治療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（薬物療法、予防接種、その他）、用途別（正常（脾腫ではない）、中程度の脾腫、重度の脾腫）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の脾腫治療法市場動向 ・主要企業別マーケットシェア ・脾腫治療法の種類別市場規模2014-2019 （薬物療法、予防接種、その他） ・脾腫治療法の用途別市場規模2014-2019 （正常（脾腫ではない）、中程度の脾腫、重度の脾腫） ・脾腫治療法の北米市場：主要企業・種類別/用途別市場規模 ・脾腫治療法のヨーロッパ市場：主要企業・種類別/用途別市場規模...Splenomegaly is an enlargement of the spleen.The spleen usually lies in the left upper quadrant (LUQ) of the human abdomen. Splenomegaly is one of the four cardinal signs of hypersplenism which include: some reduction in number of circulating blood cells affecting granulocytes, erythrocytes or platelets in any combination; a compensatory proliferative response in the bone marrow; and the potential for correction of these abnormalities by splenectomy. The increasing demand for targeted therapy is one of the critical reasons that will drive splenomegaly therapeutics market growth. Targeted therapy is a novel approach used to treat malignancies without harming the peripheral healthy...

    • ◆H&Iグローバルリサーチのお客様（例）◆